IPHA Message Board Post 10037986 | Innate Pharma S.A.
home / stock / ipha / ipha message board
Wallstreetsifu
(investorshub)
Posted on: Sep/03/2021 18:39:11
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165771190
tHANKS!!
News, Short Squeeze, Breakout and More Instantly...
Innate Pharma S.A. Company Name:
IPHA Stock Symbol:
Market:
-
In heavily pretreated patients with mycosis fungoides, treatment with lacutamab results in meaningful anti-tumor activity regardless of baseline KIR3DL2 expression level. Lacutamab was well-tolerated with a safety profile consistent with prior studies. Innate will host a virtual KOL...
-
Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“ Innate ” or the “ Company ”) today announced members of its executive team are scheduled to participate in the upcoming conferences, detailed below. Participants will include Hervé...
-
Top line results of TELLOMAK Phase 2 trial in mycosis fungoides confirming promising clinical activity of lacutamab Two posters on IPH6501, Innate’s second generation ANKET ® , for the treatment of relapsed/refractory CD20-expressing B-cell Non-Hodgkin's Lymphoma ...